The LRIG1 genetic risk variant is located in intron 2, relatively close to exon 3, where differential mRNA splicing is one potential functional mechanism, but the exact mechanism by which the increased glioma risk is conveyed is not understood. The gene discussed is LRIG1; the disease is central nervous system cancer.